share_log

Aclaris Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Vivo Opportunity Fund Holdings, L.P.(7.4%),Vivo Opportunity, LLC(7.4%), etc.

Aclaris Therapeutics | SC 13G:超過5%持股股東披露文件-Vivo Opportunity Fund Holdings, L.P.(7.4%),Vivo Opportunity, LLC(7.4%)等

美股SEC公告 ·  2024/11/21 13:55
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息